Claudio Soto
#122,474
Most Influential Person Now
Researcher
Claudio Soto's AcademicInfluence.com Rankings
Claudio Sotocomputer-science Degrees
Computer Science
#4998
World Rank
#5281
Historical Rank
Computational Linguistics
#590
World Rank
#602
Historical Rank
Machine Learning
#1164
World Rank
#1184
Historical Rank
Artificial Intelligence
#1394
World Rank
#1423
Historical Rank
Download Badge
Computer Science
Claudio Soto's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Claudio Soto Influential?
(Suggest an Edit or Addition)Claudio Soto's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Unfolding the role of protein misfolding in neurodegenerative diseases (2003) (1297)
- Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding (2001) (1218)
- Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme (1996) (974)
- β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy (1998) (810)
- In Vitro Generation of Infectious Scrapie Prions (2005) (778)
- Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases (2018) (536)
- Converting a peptide into a drug: strategies to improve stability and bioavailability. (2002) (505)
- Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. (1996) (411)
- Caspase‐12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein (2003) (408)
- An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease (1997) (381)
- Protein misfolding and neurodegeneration. (2008) (343)
- Protein misfolding and disease; protein refolding and therapy (2001) (334)
- Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis (2000) (332)
- Detection of prions in blood (2005) (320)
- Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy (2020) (316)
- Inhibition of Alzheimer β-Fibrillogenesis by Melatonin* (1998) (305)
- Ultra-efficient Replication of Infectious Prions by Automated Protein Misfolding Cyclic Amplification* (2006) (303)
- The -Helical to -Strand Transition in the Amino-terminal Fragment of the Amyloid -Peptide Modulates Amyloid Formation * (1995) (303)
- Production of cattle lacking prion protein (2007) (301)
- Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. (1995) (272)
- A novel human disease with abnormal prion protein sensitive to protease (2008) (270)
- Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides (2000) (268)
- Development of a Biochemical Diagnosis of Parkinson Disease by Detection of &agr;-Synuclein Misfolded Aggregates in Cerebrospinal Fluid (2017) (262)
- Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. (2006) (260)
- Presymptomatic Detection of Prions in Blood (2006) (236)
- Reduction of amyloid load and cerebral damage in transgenic mouse model of Alzheimer's disease by treatment with a β‐sheet breaker peptide (2002) (231)
- Type 2 diabetes as a protein misfolding disease. (2015) (230)
- Prion Strain Mutation Determined by Prion Protein Conformational Compatibility and Primary Structure (2010) (218)
- Modeling amyloid beta and tau pathology in human cerebral organoids (2018) (200)
- The Disulfide Isomerase Grp58 Is a Protective Factor against Prion Neurotoxicity (2005) (199)
- Transmissible Proteins: Expanding the Prion Heresy (2012) (191)
- Crossing the Species Barrier by PrPSc Replication In Vitro Generates Unique Infectious Prions (2008) (189)
- Misfolded protein aggregates: mechanisms, structures and potential for disease transmission. (2011) (188)
- Pharmacological Profiles of Peptide Drug Candidates for the Treatment of Alzheimer's Disease* (2003) (180)
- Molecular Cross Talk between Misfolded Proteins in Animal Models of Alzheimer's and Prion Diseases (2010) (179)
- Cell‐free propagation of prion strains (2008) (178)
- Apolipoprotein J and Alzheimer's amyloid beta solubility. (1996) (171)
- Prion hypothesis: the end of the controversy? (2011) (163)
- Cyclic amplification of protein misfolding: application to prion-related disorders and beyond (2002) (163)
- The prion strain phenomenon: molecular basis and unprecedented features. (2007) (161)
- Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis (2008) (158)
- Prions in the urine of patients with variant Creutzfeldt-Jakob disease. (2014) (156)
- Fibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structure (1995) (151)
- De novo induction of amyloid-β deposition in vivo (2012) (151)
- Pre‐symptomatic detection of prions by cyclic amplification of protein misfolding (2005) (150)
- Cross-Seeding of Misfolded Proteins: Implications for Etiology and Pathogenesis of Protein Misfolding Diseases (2013) (149)
- Isolation and characterization of a proteinase K-sensitive PrPSc fraction. (2006) (148)
- Structural Determinants of the Alzheimer's Amyloid β‐Peptide (1994) (148)
- Protein misfolding cyclic amplification for diagnosis and prion propagation studies. (2006) (146)
- Disrupting β-Amyloid Aggregation for Alzheimer Disease Treatment (2007) (145)
- Detection of misfolded Aβ oligomers for sensitive biochemical diagnosis of Alzheimer's disease. (2014) (144)
- BDNF/NF-κB Signaling in the Neurobiology of Depression. (2017) (135)
- Molecular interaction between type 2 diabetes and Alzheimer’s disease through cross-seeding of protein misfolding (2016) (130)
- IRE1 signaling exacerbates Alzheimer’s disease pathogenesis (2017) (130)
- Accelerated High Fidelity Prion Amplification Within and Across Prion Species Barriers (2008) (128)
- De Novo Generation of Infectious Prions In Vitro Produces a New Disease Phenotype (2009) (123)
- Plaque busters: strategies to inhibit amyloid formation in Alzheimer's disease. (1999) (121)
- The intricate mechanisms of neurodegeneration in prion diseases. (2011) (119)
- β-sheet breaker peptide prevents Aβ-induced spatial memory impairments with partial reduction of amyloid deposits (2004) (118)
- Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease (2016) (118)
- Amyloid Formation Modulates the Biological Activity of a Bacterial Protein* (2005) (117)
- The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysis. (1996) (116)
- Detection of infectious prions in urine (2008) (116)
- Role of Protein Misfolding and Proteostasis Deficiency in Protein Misfolding Diseases and Aging (2013) (115)
- Beta-sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood-brain barrier permeability and resistance to proteolytic degradation in plasma. (1999) (113)
- Protein misfolding cyclic amplification of infectious prions (2012) (112)
- Inhibition of Alzheimer beta-fibrillogenesis by melatonin. (1998) (112)
- The controversial protein-only hypothesis of prion propagation (2004) (111)
- Estimating prion concentration in fluids and tissues by quantitative PMCA (2010) (110)
- The Interaction between Apolipoprotein E and Alzheimers Amyloid -Peptide Is Dependent on -Peptide Conformation (*) (1996) (109)
- Generation of a New Form of Human PrPSc in Vitro by Interspecies Transmission from Cervid Prions* (2011) (106)
- High-resolution structure of infectious prion protein: the final frontier (2012) (105)
- Comparative study of cerebrospinal fluid α‐synuclein seeding aggregation assays for diagnosis of Parkinson's disease (2019) (103)
- Stressing out the ER: a role of the unfolded protein response in prion-related disorders. (2006) (97)
- Diagnosing prion diseases: needs, challenges and hopes (2004) (96)
- Smoking exacerbates amyloid pathology in a mouse model of Alzheimer’s disease (2013) (96)
- Grass plants bind, retain, uptake, and transport infectious prions. (2015) (96)
- De novo induction of amyloid-β deposition in vivo (2013) (90)
- Inhibition of protein misfolding and aggregation by natural phenolic compounds (2018) (86)
- Prion Protein Misfolding Affects Calcium Homeostasis and Sensitizes Cells to Endoplasmic Reticulum Stress (2010) (82)
- The length of Amyloid-β in Hereditary Cerebral Hemorrhage with Amyloidosis, Dutch Type (1996) (82)
- Alzheimer’s and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches (1999) (81)
- In Vivo Generation of Neurotoxic Prion Protein: Role for Hsp70 in Accumulation of Misfolded Isoforms (2009) (78)
- Traumatic Brain Injury Induces Tau Aggregation and Spreading (2019) (77)
- In Vivo Reversal of Amyloid‐β Lesions in Rat Brain (2000) (76)
- Cyclic amplification of protein misfolding and aggregation. (2005) (74)
- Is loss of function of the prion protein the cause of prion disorders? (2003) (74)
- Perturbation of Endoplasmic Reticulum Homeostasis Facilitates Prion Replication* (2007) (73)
- The Endoplasmic Reticulum Chaperone GRP78/BiP Modulates Prion Propagation in vitro and in vivo (2017) (73)
- Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone. (1999) (72)
- Amyloid-beta and tau pathology following repetitive mild traumatic brain injury. (2017) (71)
- Role of calcineurin in neurodegeneration produced by misfolded proteins and endoplasmic reticulum stress. (2011) (68)
- Cross currents in protein misfolding disorders: interactions and therapy. (2009) (66)
- Microcin Amyloid Fibrils A Are Reservoir of Toxic Oligomeric Species (2012) (64)
- Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism (2017) (62)
- Prion Protein Glycosylation Is Not Required for Strain-Specific Neurotropism (2009) (62)
- Two conformational states of amyloid β-peptide: implications for the pathogenesis of Alzheimer's disease (1995) (62)
- Bactericidal Activity of both Secreted and Nonsecreted Microcin E492 Requires the Mannose Permease (2006) (61)
- Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease brain supernatants. (1997) (61)
- Cellular factors implicated in prion replication (2010) (59)
- Calcineurin Inhibition at the Clinical Phase of Prion Disease Reduces Neurodegeneration, Improves Behavioral Alterations and Increases Animal Survival (2010) (59)
- Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, Gelsolin and AA amyloids (1995) (57)
- Disrupting beta-amyloid aggregation for Alzheimer disease treatment. (2007) (55)
- Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies. (2020) (54)
- Prions: disease propagation and disease therapy by conformational transmission. (2001) (53)
- Prion replication alters the distribution of synaptophysin and caveolin 1 in neuronal lipid rafts. (2004) (52)
- Amyloid inhibitors and beta-sheet breakers. (2005) (50)
- Prion-like features of misfolded Aβ and tau aggregates. (2015) (50)
- The Protein-disulfide Isomerase ERp57 Regulates the Steady-state Levels of the Prion Protein* (2015) (50)
- Beta-sheet breaker peptide prevents Abeta-induced spatial memory impairments with partial reduction of amyloid deposits. (2004) (49)
- The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease (2019) (49)
- Inhibition of protein misfolding and aggregation by small rationally-designed peptides. (2006) (48)
- Protein misfolding and disease: the case of prion disorders (2003) (47)
- Molecular mechanisms of neurotoxicity of pathological prion protein. (2004) (47)
- Pathways of Prion Spread during Early Chronic Wasting Disease in Deer (2017) (45)
- The intriguing prion disorders (2006) (45)
- Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential (2021) (45)
- Structural determinants of the Alzheimer's amyloid beta-peptide. (1994) (44)
- Titration of biologically active amyloid–β seeds in a transgenic mouse model of Alzheimer's disease (2015) (44)
- Cyclic amplification of prion protein misfolding. (2012) (44)
- The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease. (1996) (43)
- Inhibiting the conversion of soluble amyloid‐β peptide into abnormally folded amyloidogenic intermediates: relevance for Alzheimer's disease therapy (2000) (42)
- Beta‐sheet breaker strategy for the treatment of Alzheimer's disease (2002) (42)
- High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease (2021) (42)
- Aggregate-Depleted Brain Fails to Induce Aβ Deposition in a Mouse Model of Alzheimer's Disease (2014) (40)
- Genome-Wide Association and Mechanistic Studies Indicate That Immune Response Contributes to Alzheimer’s Disease Development (2018) (40)
- Increased susceptibility to Aβ toxicity in neuronal cultures derived from familial Alzheimer’s disease (PSEN1-A246E) induced pluripotent stem cells (2017) (39)
- Bacterial DNA promotes Tau aggregation (2019) (39)
- Abnormal calcium homeostasis and protein folding stress at the ER (2011) (38)
- The prionoses and other conformational disorders. (1998) (38)
- Distinct properties of wild‐type and the amyloidogenic human cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type (2001) (38)
- Recent US Case of Variant Creutzfeldt-Jakob Disease—Global Implications (2015) (38)
- Detection of Prions in Blood of Cervids at the Asymptomatic Stage of Chronic Wasting Disease (2017) (37)
- Brains from non-Alzheimer’s individuals containing amyloid deposits accelerate Aβ deposition in vivo (2013) (37)
- Computational selection of inhibitors of Abeta aggregation and neuronal toxicity. (2009) (36)
- In vivo reversal of amyloid-beta lesions in rat brain. (2000) (35)
- Prion-Like Protein Aggregates and Type 2 Diabetes. (2017) (35)
- Alzheimer's β‐amyloid peptide is conformationally modified by apolipoprotein E in vitro (1996) (35)
- Maturation of Human Tripeptidyl-peptidase I in Vitro* (2004) (34)
- Passage of murine scrapie prion protein across the mouse vascular blood-brain barrier. (2004) (34)
- Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides. (2000) (34)
- THE INTERACTION BETWEEN APOLIPOPROTEIN E AND ALZHEIMERʼS AMYLOID β-PEPTIDE IS DEPENDENT ON β-PEPTIDE CONFORMATION (1996) (34)
- Changes in the Glycosylation Pattern of Prion Protein in Murine Scrapie (2002) (33)
- Biochemical and structural studies of the prion protein polymorphism (2001) (33)
- Efficient prion disease transmission through common environmental materials (2018) (33)
- Strain-dependent profile of misfolded prion protein aggregates (2016) (33)
- Are β-sheet breaker peptides dissolving the therapeutic problem of Alzheimer’s disease? (2002) (32)
- Generation of a humanized Aβ expressing mouse demonstrating aspects of Alzheimer’s disease-like pathology (2021) (32)
- The ecology of chronic wasting disease in wildlife (2019) (30)
- Extracellular matrix regulates the amount of the β‐amyloid precursor protein and its amyloidogenic fragments (1996) (29)
- The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation. (1996) (29)
- Alpha‐Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure (2021) (27)
- The stress of prion disease (2016) (27)
- In Vivo Spreading of Tau Pathology (2012) (26)
- Inhibition of Alzheimer b-Fibrillogenesis by Melatonin* (1998) (25)
- Generation of prions in vitro and the protein-only hypothesis (2010) (24)
- Alzheimer's β‐amyloid vasoactivity: identification of a novel β‐amyloid conformational intermediate (1998) (23)
- Sodium dodecyl sulfate-resistant complexes of Alzheimer's amyloid beta-peptide with the N-terminal, receptor binding domain of apolipoprotein E. (2000) (23)
- Prion-like characteristics of the bacterial protein Microcin E492 (2017) (23)
- Constraining the loop, releasing prion infectivity (2009) (22)
- Reduction of prion infectivity in packed red blood cells. (2008) (20)
- Treatment with a Non-toxic, Self-replicating Anti-prion Delays or Prevents Prion Disease In vivo (2017) (20)
- In Vitro detection of Chronic Wasting Disease (CWD) prions in semen and reproductive tissues of white tailed deer bucks (Odocoileus virginianus) (2019) (19)
- Initial fate of prions upon peripheral infection: half‐life, distribution, clearance, and tissue uptake (2011) (18)
- Natural animal models of neurodegenerative protein misfolding diseases. (2012) (18)
- Adaptive selection of a prion strain conformer corresponding to established North American CWD during propagation of novel emergent Norwegian strains in mice expressing elk or deer prion protein. (2021) (17)
- Kosmotropic Anions Promote Conversion of Recombinant Prion Protein into a PrPSc-Like Misfolded Form (2012) (17)
- Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70) (2019) (17)
- Peripherally administrated prions reach the brain at sub‐infectious quantities in experimental hamsters (2014) (17)
- Reduction of Blood Amyloid-β Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition. (2016) (16)
- Beta-sheet breakers for Alzheimer's disease therapy. (2004) (16)
- Preclinical Detection of Prions in Blood of Nonhuman Primates Infected with Variant Creutzfeldt-Jakob Disease (2020) (16)
- Modeling Traumatic Brain Injury in Human Cerebral Organoids (2021) (15)
- Detection of Misfolded α-Synuclein Aggregates in Cerebrospinal Fluid by the Protein Misfolding Cyclic Amplification Platform. (2019) (15)
- β Structure motif recognition by anti‐gliadin antibodies in coeliac disease (1998) (15)
- PMCA-replicated PrPD in urine of vCJD patients maintains infectivity and strain characteristics of brain PrPD: Transmission study (2019) (15)
- β-Amyloid Disrupting Drugs (1999) (14)
- Emerging roles of the unfolded protein response signaling in physiology and disease. (2006) (13)
- Prions efficiently cross the intestinal barrier after oral administration: Study of the bioavailability, and cellular and tissue distribution in vivo (2016) (13)
- Alzheimer's amyloid-β aggregation is modulated by the interaction of multiple factors (1997) (13)
- Alzheimer's beta-amyloid vasoactivity: identification of a novel beta-amyloid conformational intermediate. (1998) (13)
- Transmission of cerebral amyloid pathology by peripheral administration of misfolded Aβ aggregates (2021) (12)
- Molecular biology of the amyloid of Alzheimer's disease. An overview. (1992) (12)
- Protein misfolding disorders and rational design of antimisfolding agents. (2006) (12)
- Impaired Peripheral Lymphatic Function and Cerebrospinal Fluid Outflow in a Mouse Model of Alzheimer's Disease. (2019) (12)
- Induced Pluripotent Stem Cell-Derived Neural Precursors Improve Memory, Synaptic and Pathological Abnormalities in a Mouse Model of Alzheimer’s Disease (2021) (11)
- Infusion of blood from mice displaying cerebral amyloidosis accelerates amyloid pathology in animal models of Alzheimer’s disease (2020) (11)
- Identification of circulating microRNA signatures as potential biomarkers in the serum of elk infected with chronic wasting disease (2019) (11)
- Amyloid pathology arrangements in Alzheimer’s disease brains modulate in vivo seeding capability (2021) (11)
- Role of Prion Replication in the Strain-dependent Brain Regional Distribution of Prions* (2016) (11)
- Are beta-sheet breaker peptides dissolving the therapeutic problem of Alzheimer's disease? (2002) (11)
- North American and Norwegian Chronic Wasting Disease prions exhibit different potential for interspecies transmission and zoonotic risk. (2021) (11)
- The clock modulator Nobiletin mitigates astrogliosis‐associated neuroinflammation and disease hallmarks in an Alzheimer’s disease model (2022) (11)
- Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease (2021) (10)
- Delaying aging in Caenorhabditis elegans with protein aggregation inhibitors. (2017) (10)
- The Extent of Protease Resistance of Misfolded Prion Protein Is Highly Dependent on the Salt Concentration* (2013) (9)
- Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression (2021) (9)
- Human Endogenous Retroviruses in Glioblastoma Multiforme (2021) (9)
- Endoplasmic reticulum stress, PrP trafficking, and neurodegeneration. (2008) (9)
- Lack of prion transmission by sexual or parental routes in experimentally infected hamsters (2013) (9)
- Protein Misfolding in Neurodegenerative Diseases: The Key Pending Questions (2013) (8)
- Application of PMCA to screen for prion infection in a human cell line used to produce biological therapeutics (2019) (8)
- Protein Misfolding Disorders: A Trip into the ER (2018) (8)
- Altering prion replication for therapy and diagnosis of transmissible spongiform encephalopathies. (2001) (8)
- Therapeutic strategies against protein misfolding in neurodegenerative diseases (2009) (7)
- Prions: The New Biology of Proteins (2005) (7)
- Erythrocyte adenosine A2B receptor prevents cognitive and auditory dysfunction by promoting hypoxic and metabolic reprogramming (2021) (6)
- Peripheral Delivery of Neural Precursor Cells Ameliorates Parkinson’s Disease-Associated Pathology (2019) (6)
- Reversibility of prion-induced neurodegeneration (2007) (6)
- Role of Prion Protein Oligomers in the Pathogenesis of Transmissible Spongiform Encephalopathies (2012) (6)
- Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson’s Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology (2021) (5)
- Detection of CWD prions in naturally infected white-tailed deer fetuses and gestational tissues by PMCA (2021) (5)
- HIV/AIDS: modified stem cells in the spotlight (2014) (5)
- Prion Dissemination through the Environment and Medical Practices: Facts and Risks for Human Health (2021) (5)
- Multi-scale modeling for systematically understanding the key roles of microglia in AD development (2021) (4)
- Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid (2023) (3)
- Advances in Prion Detection (2007) (3)
- Development of a Fluorescent Quenching Based High Throughput Assay to Screen for Calcineurin Inhibitors (2015) (3)
- Protocol for controlled cortical impact in human cerebral organoids to model traumatic brain injury (2021) (3)
- (De)stabilization of Alpha-Synuclein Fibrillary Aggregation by Charged and Uncharged Surfactants (2021) (3)
- Preventive and therapeutic reduction of amyloid deposition and behavioral impairments in a model of Alzheimer’s disease by whole blood exchange (2022) (3)
- Mitochondrial transplant to replenish damaged mitochondria: A novel therapeutic strategy for neurodegenerative diseases? (2021) (2)
- Prion Protein Misfolding and Brain Degeneration (2003) (2)
- Correction: The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease (2020) (2)
- Erratum: Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis (Proceedings of the National Academy of Sciences of the United States of America (2008) 105:2 (757-762) DOI: 10.1073/pnas.0711094105) (2009) (2)
- Are Amyloids Infectious (2009) (2)
- Longitudinal Assessment of Tau-Associated Pathology by 18F-THK5351 PET Imaging: A Histological, Biochemical, and Behavioral Study (2021) (2)
- Strategies for Alzheimer's Disease Diagnosis (2009) (2)
- Corrigendum to “Peripherally administrated prions reach the brain at sub‐infectious quantities in experimental hamsters” [FEBS Lett. 588 (2014) 795–800] (2014) (2)
- Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases (2018) (2)
- Signaling Pathways Controling Prion Neurotoxicity: Role of Endoplasmic Reticulum Stress-Mediated Apoptosis (2005) (2)
- Inhibition of Alzheimer's beta (Aβ) amyloid fibril formation (1997) (2)
- Animal models for neurodegenerative diseases associated to accumulation of misfolded protein aggregates. (2012) (1)
- Development of a novel pharmacophore model to screen specific inhibitors for the serine-threonine protein phosphatase calcineurin (2022) (1)
- In vivo disrupting of amyloid deposition after injection of β-sheet breaker peptide into cerebral ventricle (2000) (1)
- Extensive accumulation of misfolded protein aggregates during natural aging and senescence (2023) (1)
- 581 Inhibiting amyloid formation by peptides with anti-β-sheet conformation: A novel therapeutic approach for alzheimer's disease (1996) (1)
- Identification of Multicolor Fluorescent Probes for Heterogeneous Aβ Deposits in Alzheimer’s Disease (2022) (1)
- 1,2,4‐trihydroxynaphthalene‐2‐O‐&bgr;‐D‐glucopyranoside delays amyloid‐&bgr;42 aggregation and reduces amyloid cytotoxicity (2018) (1)
- Design of Inhibitors of Amyloid-β Misfolding and Aggregation for Alzheimer's Therapy (2007) (1)
- Cyclic Amplification of Scrapie Prion Protein: Implications for Diagnosis (2003) (1)
- THE EFFECT OF REPETITIVE MILD TRAUMATIC BRAIN INJURY ON TAU PATHOLOGY (2018) (1)
- Correction: De Novo Generation of Infectious Prions In Vitro Produces a New Disease Phenotype (2013) (1)
- Correction to: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease (2021) (1)
- Chaperoning Amyloid in Alzheimer’s Disease: The Art of Avoiding Sticky Situations? (1996) (1)
- Editorial [Hot Topic: Animal Models for Neurodegenerative Diseases Associated to Accumulation of Misfolded Protein Aggregates (Executive Guest Editor: Claudio Soto)] (2012) (1)
- Protein misfolding cyclic amplification (2013) (1)
- PMCA for ultrasensitive detection of prions and to study disease biology (2022) (1)
- Correction: Prion Protein Misfolding Affects Calcium Homeostasis and Sensitizes Cells to Endoplasmic Reticulum Stress (2011) (1)
- Inhibition of protein misfolding and aggregation by natural phenolic compounds (2018) (1)
- Uptake, Retention, and Excretion of Infectious Prions by Experimentally Exposed Earthworms (2021) (1)
- Caspase‐12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein (2021) (1)
- HUMAN WILD TYPE Aβ KNOCK-IN MICE AS A BASIS TO STUDY SPORADIC ALZHEIMER’S DISEASE (2019) (0)
- Cell biology, genetic and putative function of the normal prion protein (2005) (0)
- IN VIVO PROPAGATION OF SYNTHETIC Aβ CONFORMATIONAL STRAINS (2018) (0)
- 700 Binding between apolipoprotein E and amyloid β is dependent on secondary structure (1996) (0)
- Application of PMCA to screen for prion infection in a human cell line used to produce biological therapeutics (2019) (0)
- AMYLOID BETA AGGREGATES PRESENT IN AGED CATTLE BRAIN ACCELERATE ALZHEIMER’S PATHOLOGY (2017) (0)
- No. 119 Relation Between Length of Post Traumatic Amnesia and Cognitive Functional Impairment in Adult Patients With Traumatic Brain Injury in Chile (2014) (0)
- Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson’s Disease Patient (2023) (0)
- No. 22 Impact of Early Occupational Therapy on the Cognitive and Functional Recovery in Adult Patients with Traumatic Brain Injury in Chile (2014) (0)
- Identification of biomarkers for diagnosing and monitoring therapy in the treatment of neurologic disorders (2021) (0)
- Neural Precursors Derived from Embryonic and Mesenchymal Stem Cells Ameliorate Parkinson's Disease Associated Motor Impairment (2019) (0)
- Infusion of blood from mice displaying cerebral amyloidosis accelerates amyloid pathology in animal models of Alzheimer’s disease (2020) (0)
- Tau deletion promotes peripheral insulin resistance (2020) (0)
- PMCA-replicated PrPD in urine of vCJD patients maintains infectivity and strain characteristics of brain PrPD: Transmission study (2019) (0)
- PRION-LIKE PROPERTIES OF MISFOLDED AMYLOID-β AGGREGATES IN ANIMAL MODELS (2014) (0)
- Amyloid pathology arrangements in Alzheimer’s disease brains modulate in vivo seeding capability (2021) (0)
- Tau Loss of Function, by Deletion or Aggregation, Contributes to Peripheral Insulin Resistance (2022) (0)
- Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy (2020) (0)
- Seminars in Cell & Developmental Biology (2011) (0)
- Amyloid oligomers prevent protein folding (2018) (0)
- The role of protein misfolding and aggregation in type 2 diabetes (2015) (0)
- Reduction of Prion Infectivity in Packed Red Cells by Separation of Whole Blood and Washing of the Red Cell Fraction. (2007) (0)
- Generation and propagation of infectious prions by cyclic amplification of protein misfolding (2008) (0)
- The infectious nature of protein misfolding disorders (2009) (0)
- Correlation between 18F‐THK5351 tau PET imaging and the progression of neuropathology and clinical signs in a mouse model (2021) (0)
- Infusion of neural precursors improves memory impairment in mouse models of Alzheimer’s disease (2020) (0)
- INDUCTION OF DIFFERENT BRAIN PATHOLOGY IN MICE TREATED WITH TWO MISFOLDED Aβ CONFORMERS (2019) (0)
- Detection of misfolded protein aggregated in HIV‐infected people (2020) (0)
- The prion protein: structure, conversion, and mechanism of propagation (2005) (0)
- SEEDING OF CEREBRAL AMYLOID-BETA MISFOLDING BY DIFFERENT ROUTES OF ADMINISTRATION (2017) (0)
- Amyloid-β Transmissibility (2013) (0)
- Correction for Hetz et al., Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis (2009) (0)
- Endoplasmic reticulum stress in neurodegenerative diseases (2012) (0)
- 724 Apollpoprotein J is associated to Alzheimer's amyioid β in biological fluids and brain lesions (1996) (0)
- Corrigendum (2021) (0)
- Emerging Therapeutic Targets - Volume One Central & Peripheral Nervous Systems (1997) (0)
- Anti‐Misfolding and Anti‐Fibrillization Therapies for Protein Misfolding Disorders (2010) (0)
- HIV/AIDS: modified stem cells in the spotlight (2014) (0)
- The infectious agent and the prion hypothesis (2005) (0)
- Editorial [ Therapeutics for Protein Misfolding Diseases Executive Editor: Claudio Soto ] (2006) (0)
- REPETITIVE MILD TRAUMATIC BRAIN INJURY TRIGGERS AND EXACERBATES TAU PATHOLOGY AND BEHAVIOR (2019) (0)
- Prions: a common phenomenon in biology? (2005) (0)
- AGED CATTLE BRAIN DISPLAYS ALZHEIMER'S-LIKE PATHOLOGY THAT CAN BE PROPAGATED IN A PRION-LIKE MANNER (2018) (0)
- Prion strains, species barriers, and multiple conformations of the prion protein (2005) (0)
- Amyloid propagation in a sporadic model of Alzheimer's disease (2020) (0)
- Longitudinal assessment of tau pet imaging and its correlation with neuropathology and clinical signs progression (2020) (0)
- Transmission of Alzheimer's disease by seeding and cross-seeding (2009) (0)
- Biochemical detection of misfolded amyloid-beta oligomers for sensitive diagnosis of Alzheimer?s disease (2013) (0)
- The Endoplasmic Reticulum Chaperone GRP 78 / BiP Modulates (2017) (0)
- Peptides Inhibitor of Amyloidogenesis in Alzheimer’s Disease (1997) (0)
- Smoking acelerates amyloid formation and associated neurodegenerative alterations in a transgenic mouse model of alzheimerâś disease (2011) (0)
- Claudio Soto of Toxic Oligomeric Species Microcin Amyloid Fibrils A Are Reservoir Protein Structure and Folding (2012) (0)
- Neurodegeneration in prion diseases (2005) (0)
- Aged Cattle Brain Displays Alzheimer's Disease-Like Pathology and Promotes Brain Amyloidosis in a Transgenic Animal Model (2022) (0)
- Systematically understanding the key roles of microglia in AD development (2019) (0)
- The story of the rogue prions (2014) (0)
- Battle of the Genomes : The Struggle for Survival in a Microbial World (2019) (0)
- Protein Misfolding, a Common Mechanism in the Pathogenesis of Neurodegenerative Diseases (2008) (0)
- Brains from non-Alzheimer’s individuals containing amyloid deposits accelerate Aβ deposition in vivo (2013) (0)
- Editorial: Novel mechanisms involved in aging and neurodegeneration: Seeking potential therapeutic targets for neurodegenerative diseases (2022) (0)
- Bacterial DNA promotes Tau aggregation (2020) (0)
- Altering Brain Amyloidosis by Intra-Lingual and Extra-Nasal Exposure of Aβ Aggregates (2022) (0)
- Prion Protein Glycosylation Is Not Required for Strain-Specific Neurotropism (cid:1) † (2009) (0)
- Explorer Prions in the urine of patients with variant Creutzfeldt-Jakob disease (2017) (0)
- NEURAL PRECURSORS DERIVED FROM EMBRYONIC AND MESENCHYMAL STEM CELLS AMELIORATE PARKINSON’S DISEASE-ASSOCIATED MOTOR IMPAIRMENT (2018) (0)
- Human and animal diseases: clinical symptoms, epidemiology, and neuropathology (2005) (0)
- Correction: Prion Protein Misfolding Affects Calcium Homeostasis and Sensitizes Cells to Endoplasmic Reticulum Stress (2022) (0)
- Tau deletion or loss of function promotes peripheral insulin resistance (2021) (0)
- PERIPHERAL INOCULATION OF NEURAL PRECURSORS IMPROVES PARKINSON’S DISEASE PATHOLOGY (2019) (0)
- Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease (2022) (0)
- No. 90 Influence of Cognitive-Communication Disorder on Dysphagia Prognosis in Patients With Brain Injury (2014) (0)
- Title Type 2 diabetes as a protein misfolding disease Permalink (2015) (0)
- Detection of Prions in Blood of Cervids at the Asymptomatic Stage of Chronic Wasting Disease (2017) (0)
- Induction of cerebral amyloidosis and memory impairments by blood transfusion in mice models of Alzheimer's disease (2011) (0)
- Cyclic amplification of prion protein misfolding: rationale, applications, and perspectives (2005) (0)
- Editorial [Hot Topic: Emerging Roles of the Unfolded Protein Response Signaling in Physiology and Disease (Executive Editor: Claudio A. Hetz and Claudio Soto )] (2006) (0)
- Other diseases of protein misfolding (2005) (0)
- Correction: The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease (2020) (0)
- Altering prion protein misfolding for therapy and diagnosis of transmissible spongiform encephalopathies (2002) (0)
- Prion and Prion-like Diseases in Humans (2013) (0)
- P1-116 NEUROFILAMENT LIGHT LEVELS IN THE CEREBROSPINAL FLUID ARE UNCOUPLED OFAMYLOIDOSIS IN LATE STAGE PATHOGENESIS OFAPP TRANSGENIC MICE (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Claudio Soto?
Claudio Soto is affiliated with the following schools:
